Medical devices, healthcare technology and the business of care
510(k) clearance · K262426

Medical Diode Laser (S1Pro+, S1Pro K15, S1Pro N6, S1Pro N75)

Wuhan Pioon Technology Co., Ltd. · Decision date Sep 10, 2026

MEDTECHLEDGER EXPLANATIONK262426

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 10, 2026 for K262426, a traditional 510(k) from Wuhan Pioon Technology Co., Ltd. covering the Medical Diode Laser under model designations S1Pro+, S1Pro K15, S1Pro N6 and S1Pro N75. The device falls under regulation 878.4810, product code GEX, in the General & Plastic Surgery specialty, with the same panel listed for review. The application was received July 16, 2026; SESE denotes clearance to market, not premarket approval.

The available FDA correspondence excerpt describes the S1Pro+ as intended for delivery of laser light to soft tissue in contact and non-contact modes, and states that the device's 980nm laser is generally indicated for incision, excision, vaporization, ablation, hemostasis or coagulation of soft tissue. The excerpt does not establish whether those indications extend to the K15, N6 and N75 configurations, nor does it give wavelengths, power settings, patient-selection criteria or treatment parameters; those details remain in the full FDA documents. No third-party review, combination product status or change control plan was recorded.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 10, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262426
Regulatory pathway
510(k) premarket notification
Product code
GEX
Decision code
SESE
Decision date
Sep 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Powered Laser Surgical Instrument.

Product code
GEX
FDA device class
2

FDA decision timeline

  1. K262426 received

    Application receipt date recorded by FDA.

  2. K262426 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GEX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Wuhan Pioon Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Wuhan

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records